Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Chronic Heart Failure

  Free Subscription


26.02.2024

2 Am Heart J
4 Am J Cardiol
1 BMJ
1 Circ Arrhythm Electrophysiol
1 Circ Cardiovasc Interv
1 Circ Cardiovasc Qual Outcomes
5 Circ Heart Fail
2 Circ Res
2 Clin Cardiol
1 Eur Heart J
17 Eur J Heart Fail
2 Heart
1 Hypertension
9 Int J Cardiol
2 J Am Coll Cardiol
11 J Card Fail
2 J Cardiol
1 J Mol Cell Cardiol
1 Lancet
1 PLoS Med


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am Heart J

  1. SIREN M, Leivo J, Anttonen E, Jolly SS, et al
    The Prognostic Significance of Single-Lead ST-Segment Resolution in ST-Segment Elevation Myocardial Infarction Patients Treated with Primary PCI - A Substudy of the Randomized TOTAL Trial.
    Am Heart J. 2023 Dec 16:S0002-8703(23)00347-2. doi: 10.1016/j.ahj.2023.
    PubMed         Abstract available

  2. ANDERSEN CF, Larsen JH, Jensen J, Omar M, et al
    Empagliflozin to elderly and obese patients with increased risk of developing heart failure: Study protocol for the Empire Prevent trial program.
    Am Heart J. 2024 Feb 14:S0002-8703(24)00032-2. doi: 10.1016/j.ahj.2024.
    PubMed         Abstract available


    Am J Cardiol

  3. BRAUNWALD E
    Hypertrophic Cardiomyopathy: A Brief Overview.
    Am J Cardiol. 2024;212S:S1-S3.
    PubMed         Abstract available

  4. HUTT E, Desai MY
    Medical Treatment Strategies for Hypertrophic Cardiomyopathy.
    Am J Cardiol. 2024;212S:S33-S41.
    PubMed         Abstract available

  5. MARON BJ, Rowin EJ, Maron MS
    Advances in the Management of Hypertrophic Cardiomyopathy Leading to Low Disease-Related Mortality in 2023.
    Am J Cardiol. 2024;212S:S77-S82.
    PubMed         Abstract available

  6. CHAMBERGO-MICHILOT D, Becerra-Gonzales VG, Kittipibul V, Colombo R, et al
    Racial Differences in Hospice Care Outcomes Among Patients with Advanced Heart Failure: Systematic Review and Meta-analysis.
    Am J Cardiol. 2024 Feb 19:S0002-9149(24)00096.
    PubMed         Abstract available


    BMJ

  7. WEI Y, Feng Y, Danesh Yazdi M, Yin K, et al
    Exposure-response associations between chronic exposure to fine particulate matter and risks of hospital admission for major cardiovascular diseases: population based cohort study.
    BMJ. 2024;384:e076939.
    PubMed         Abstract available


    Circ Arrhythm Electrophysiol

  8. GONZALEZ-MATOS CE, Rodriguez-Queralto O, Zaraket F, Jimenez J, et al
    Conduction System Stimulation to Avoid Left Ventricle Dysfunction.
    Circ Arrhythm Electrophysiol. 2024;17:e012473.
    PubMed         Abstract available


    Circ Cardiovasc Interv

  9. SHECHTER A, Lee M, Kaewkes D, Patel V, et al
    Implications of Mitral Annular Calcification on Outcomes Following Mitral Transcatheter Edge-to-Edge Repair.
    Circ Cardiovasc Interv. 2024;17:e013424.
    PubMed         Abstract available


    Circ Cardiovasc Qual Outcomes

  10. RAO BR, Dickert NW, Morris AA
    Ethical Complexity of Medical Treatment Affordability and Clinical Trial Diversity in Heart Failure.
    Circ Cardiovasc Qual Outcomes. 2024;17:e010227.
    PubMed        


    Circ Heart Fail

  11. PARDO SANZ A, Salido Tahoces L, Jimenez-Blanco Bravo M, Alvarez Garcia J, et al
    TAVI With ACURATE neo2 Valve in Aortic Regurgitation Due to Left Ventricular Assist Device: A Custom-Made Option.
    Circ Heart Fail. 2024 Jan 12:e010719. doi: 10.1161/CIRCHEARTFAILURE.123.010719.
    PubMed        

  12. MYHRE PL, Omland T, Shah AM
    Ongoing Enigma of NT-proBNP in HFpEF: Insights From Proteomics.
    Circ Heart Fail. 2024;17:e011428.
    PubMed        

  13. BITAR A, Colvin MM
    Beyond Tiers: Examination of the French Heart Allocation System.
    Circ Heart Fail. 2024;17:e011312.
    PubMed        

  14. MOAYEDI Y, Rodenas-Alesina E, Somerset E, Fan CPS, et al
    Enhancing the Prediction of Cardiac Allograft Vasculopathy Using Intravascular Ultrasound and Machine Learning: A Proof of Concept.
    Circ Heart Fail. 2024 Feb 5:e011306. doi: 10.1161/CIRCHEARTFAILURE.123.011306.
    PubMed         Abstract available

  15. ARABYARMOHAMMADI S, Yuan C, Viswanathan VS, Lal P, et al
    Failing to Make the Grade: Conventional Cardiac Allograft Rejection Grading Criteria Are Inadequate for Predicting Rejection Severity.
    Circ Heart Fail. 2024;17:e010950.
    PubMed         Abstract available


    Circ Res

  16. KAMRADT ML, Makarewich CA
    CHKB-DT: A Long Noncoding RNA Critical for Cardiovascular Health.
    Circ Res. 2024;134:442-444.
    PubMed        

  17. VACCA A, Schiattarella GG
    From Gut to Heart: Role of Indole-3-Propionic Acid in HFpEF.
    Circ Res. 2024;134:390-392.
    PubMed        


    Clin Cardiol

  18. ERGUI I, Salama J, Hooda U, Ebner B, et al
    In-hospital outcomes in unhoused patients with cardiogenic shock in the United States: Insights from The National Inpatient Sample 2011-2019.
    Clin Cardiol. 2024;47:e24235.
    PubMed         Abstract available

  19. ZHENG S, Li L, Jiang C, He L, et al
    Association between performance measures and clinical outcomes in patients with heart failure in China: Results from the HERO study.
    Clin Cardiol. 2024;47:e24233.
    PubMed         Abstract available


    Eur Heart J

  20. SCHMITTO JD, Shaw S, Garbade J, Gustafsson F, et al
    Fully magnetically centrifugal left ventricular assist device and long-term outcomes: the ELEVATE registry.
    Eur Heart J. 2023 Nov 30:ehad658. doi: 10.1093.
    PubMed         Abstract available


    Eur J Heart Fail

  21. PITT B, Iyer SPN, Humes HD
    New opportunity for targeting systemic inflammation in patients with heart failure through leucocyte immunomodulation.
    Eur J Heart Fail. 2024 Feb 23. doi: 10.1002/ejhf.3177.
    PubMed        


  22. Correction to 'Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology'.
    Eur J Heart Fail. 2024 Feb 20. doi: 10.1002/ejhf.3171.
    PubMed        

  23. PELLICORI P, Felker GM, Cleland JGF
    Reply to 'Vasodilators in congestive heart failure: The perfect weapon aiming just off the target?'.
    Eur J Heart Fail. 2024 Feb 20. doi: 10.1002/ejhf.3159.
    PubMed        

  24. TALHA KM, Januzzi JL Jr, Meng T, Greene SJ, et al
    Use of natriuretic peptides and echocardiography for diagnosing heart failure.
    Eur J Heart Fail. 2024 Feb 20. doi: 10.1002/ejhf.3165.
    PubMed         Abstract available

  25. MINAMISAWA M, Inciardi RM, Claggett B, Cikes M, et al
    Clinical implications of subclinical left ventricular dysfunction in heart failure with preserved ejection fraction: The PARAGON-HF study.
    Eur J Heart Fail. 2024 Feb 18. doi: 10.1002/ejhf.3167.
    PubMed         Abstract available

  26. KHAN MS, Sperry BW, Butler J
    Kidney involvement in transthyretin cardiac amyloidosis - Role of urinary albumin to creatinine ratio and need for further evidence generation.
    Eur J Heart Fail. 2024;26:74-76.
    PubMed        

  27. BERTERO E, Chiti C, Schiavo MA, Tini G, et al
    Real-world candidacy to mavacamten in a contemporary hypertrophic obstructive cardiomyopathy population.
    Eur J Heart Fail. 2024;26:59-64.
    PubMed         Abstract available

  28. SEOUDY H, Voran JC, Frank D
    Growth differentiation factor-15 in sodium-glucose cotransporter 2 inhibition: Mechanistic insights from the EMPEROR program.
    Eur J Heart Fail. 2024;26:165-166.
    PubMed        

  29. RIVAS GARCIA S, Alvarez-Garcia J
    Sacubitril/valsartan: Where mechanism meets evidence-based medicine.
    Eur J Heart Fail. 2024;26:127-129.
    PubMed        

  30. FERREIRA JP, Rossello X, Zannad F
    Mineralocorticoid receptor antagonist indication and underuse in high-risk post-myocardial infarction patients.
    Eur J Heart Fail. 2024;26:140-141.
    PubMed        

  31. ARDISSINO M, Halliday BP, de Marvao A
    The global landscape of peripartum cardiomyopathy: Morbidity, mortality, recovery and inequity.
    Eur J Heart Fail. 2024;26:43-45.
    PubMed        

  32. IOANNOU A, Rauf MU, Patel RK, Razvi Y, et al
    Albuminuria in transthyretin cardiac amyloidosis: Prevalence, progression and prognostic importance.
    Eur J Heart Fail. 2024;26:65-73.
    PubMed         Abstract available

  33. MERLO M, Setti M, Sinagra G
    Coronary artery disease and dilated cardiomyopathy: Where parallel universes merge.
    Eur J Heart Fail. 2024;26:56-58.
    PubMed        

  34. SCHOU M, Claggett B, Miao ZM, Fernandez A, et al
    Sacubitril/valsartan compared to ramipril in high-risk post-myocardial infarction patients stratified according to use of mineralocorticoid receptor antagonists: Insight from the PARADISE MI trial.
    Eur J Heart Fail. 2024;26:130-139.
    PubMed         Abstract available

  35. MAEDA D, Matsue Y, Dotare T, Sunayama T, et al
    Clinical characteristics and prognosis of patients with isolated cardiac sarcoidosis: Insights from the ILLUMINATE-CS study.
    Eur J Heart Fail. 2024;26:77-86.
    PubMed         Abstract available

  36. JACKSON AM, Bauersachs J, Petrie MC, van der Meer P, et al
    Outcomes at one year in women with peripartum cardiomyopathy: Findings from the ESC EORP PPCM Registry.
    Eur J Heart Fail. 2024;26:34-42.
    PubMed         Abstract available

  37. JONES RE, Hammersley DJ, Zheng S, McGurk KA, et al
    Assessing the association between genetic and phenotypic features of dilated cardiomyopathy and outcome in patients with coronary artery disease.
    Eur J Heart Fail. 2024;26:46-55.
    PubMed         Abstract available


    Heart

  38. GALLOO X, Fortuni F, Meucci MC, Butcher SC, et al
    Association of right atrial strain and long-term outcome in severe secondary tricuspid regurgitation.
    Heart. 2023 Oct 30:heartjnl-2023-323084. doi: 10.1136/heartjnl-2023-323084.
    PubMed         Abstract available

  39. SANGHA V
    Augmenting reality in echocardiography.
    Heart. 2023 Nov 8:heartjnl-2023-323443. doi: 10.1136/heartjnl-2023-323443.
    PubMed        


    Hypertension

  40. TAKEDA R, Hissen SL, Akins JD, Washio T, et al
    Sympathetic Neural Control at Rest and During the Cold Pressor Test in Patients With Heart Failure With Preserved Ejection Fraction.
    Hypertension. 2024 Feb 22. doi: 10.1161/HYPERTENSIONAHA.123.21918.
    PubMed         Abstract available


    Int J Cardiol

  41. GARCIA-MOLL X, Lopez L
    Safety of sacubitril/valsartan among older adults. Where real world data meet clinical trials results.
    Int J Cardiol. 2024;400:131706.
    PubMed        

  42. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
    Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
    Int J Cardiol. 2024;400:131768.
    PubMed         Abstract available

  43. SRAYA R, Amsalem I, Carasso S, Gilad O, et al
    Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
    Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
    PubMed         Abstract available

  44. DE MICHIELI L, Stoppa G, Sinigiani G, Previato L, et al
    Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy.
    Int J Cardiol. 2024;400:131804.
    PubMed         Abstract available

  45. MIGLIORE F, Schiavone M, Pittorru R, Forleo GB, et al
    Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience.
    Int J Cardiol. 2024 Jan 23:131807. doi: 10.1016/j.ijcard.2024.131807.
    PubMed         Abstract available

  46. XU L, Chen Y, Chen S, Wang G, et al
    Relationship between resting heart rate and long-term outcomes in stabilized patients with myocardial infarction: A prospective community-based cohort study.
    Int J Cardiol. 2024 Jan 24:131811. doi: 10.1016/j.ijcard.2024.131811.
    PubMed         Abstract available

  47. SIM DKL, Mittal S, Zhang J, Hung CL, et al
    Expert recommendations for the management of iron deficiency in patients with heart failure in Asia.
    Int J Cardiol. 2024 Feb 19:131890. doi: 10.1016/j.ijcard.2024.131890.
    PubMed         Abstract available

  48. GUAZZI M, Crisci G
    Exercise mean PAP to CO relationship: An insightful endpoint for testing therapeutic interventions in heart failure.
    Int J Cardiol. 2024 Feb 20:131899. doi: 10.1016/j.ijcard.2024.131899.
    PubMed        

  49. LUO Z, Gong X, Liu Y, Hao K, et al
    Mitochondrial dysfunction due to miR-210/Drd5/ROS axis is a potential mechanism of heart failure.
    Int J Cardiol. 2024 Feb 20:131897. doi: 10.1016/j.ijcard.2024.131897.
    PubMed        


    J Am Coll Cardiol

  50. BOTTINOR W, Im C, Doody DR, Armenian SH, et al
    Mortality After Major Cardiovascular Events in Survivors of Childhood Cancer.
    J Am Coll Cardiol. 2024;83:827-838.
    PubMed         Abstract available

  51. BARIANI R, Rigato I, Celeghin R, Marinas MB, et al
    Phenotypic Expression and Clinical Outcomes in Patients With Arrhythmogenic Cardiomyopathies.
    J Am Coll Cardiol. 2024;83:797-807.
    PubMed         Abstract available


    J Card Fail

  52. PENG DM, Kwiatkowski DM, Lasa JJ, Zhang W, et al
    Contemporary Care and Outcomes of Critically-ill Children With Clinically Diagnosed Myocarditis.
    J Card Fail. 2024;30:350-358.
    PubMed         Abstract available

  53. AMDANI S, Gupta D
    Improving Outcomes for Critically Ill Children With Myocarditis.
    J Card Fail. 2024;30:359-361.
    PubMed        

  54. FIROZ A, Geier S, Yanagida R, Hamad E, et al
    Heart Transplant Human Leukocyte Antigen Matching in the Modern Era.
    J Card Fail. 2024;30:362-372.
    PubMed         Abstract available

  55. DEFILIPPIS EM, Lacelle C, Garg S, Farr M, et al
    Harnessing Precision Medicine: HLA or Eplet Matching in Heart Transplantation.
    J Card Fail. 2024;30:373-375.
    PubMed        

  56. SHARIF SM, Smith JR, Bruhn EJ, Shultz AM, et al
    Impact of Structured Resistance Training on Locomotor Muscle Composition in Patients with HFpEF.
    J Card Fail. 2024;30:410-414.
    PubMed        

  57. ILONZE OJ, Pang PS
    Nebulized Milrinone: Choosing Next Steps Wisely.
    J Card Fail. 2024;30:337-339.
    PubMed        

  58. FERREIRA JP, Neves JS, Saraiva F
    Cardiovascular Prevention in Obese Patients Without Diabetes: Risk-based Strategies Are Needed.
    J Card Fail. 2024;30:418-420.
    PubMed        

  59. LALA A, Hurt MT, Mentz RJ
    The Heart as a Reminder for Oneness.
    J Card Fail. 2024;30:317-318.
    PubMed        

  60. FANG JC
    A Board of Our Own: The New American Board for Cardiovascular Medicine.
    J Card Fail. 2024;30:421.
    PubMed        

  61. JUJIC A, Molvin J, Nilsson ED, Isholt HH, et al
    Low levels of selenoprotein P associate with cognitive impairment in patients hospitalized for heart failure.
    J Card Fail. 2024 Feb 14:S1071-9164(24)00039.
    PubMed         Abstract available

  62. MARTYN T, Saef J, Bansal A, Martinez KA, et al
    Patient and Provider Factors Associated With Initiating Sodium-Glucose Cotransporter-2 Inhibitors (SGTL2i) Following FDA Approval for Heart Failure with Preserved and Mildly Reduced Ejection Fraction.
    J Card Fail. 2024 Feb 15:S1071-9164(24)00035.
    PubMed        


    J Cardiol

  63. SAITO S, Okubo S, Matsuoka T, Hirota S, et al
    Impella - Current issues and future expectations for the percutaneous, microaxial flow left ventricular assist device.
    J Cardiol. 2024;83:228-235.
    PubMed         Abstract available

  64. YAKU H, Fudim M, Shah SJ
    Role of splanchnic circulation in the pathogenesis of heart failure: State-of-the-art review.
    J Cardiol. 2024 Feb 16:S0914-5087(24)00022-4. doi: 10.1016/j.jjcc.2024.
    PubMed         Abstract available


    J Mol Cell Cardiol

  65. ANTIPENKO S, Mayfield N, Jinno M, Gunzer M, et al
    Neutrophils are indispensable for adverse cardiac remodeling in heart failure.
    J Mol Cell Cardiol. 2024;189:1-11.
    PubMed         Abstract available


    Lancet

  66. CAMPBELL P, Rutten FH, Lee MM, Hawkins NM, et al
    Heart failure with preserved ejection fraction: everything the clinician needs to know.
    Lancet. 2024 Feb 14:S0140-6736(23)02756-3. doi: 10.1016/S0140-6736(23)02756.
    PubMed         Abstract available


    PLoS Med

  67. HALL M, Smith L, Wu J, Hayward C, et al
    Health outcomes after myocardial infarction: A population study of 56 million people in England.
    PLoS Med. 2024;21:e1004343.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.